Tisch MS News

FDA Approves MSC-NP Therapy as Investigational New Drug in MS Clinical Trial: A Research Milestone

The stem cell research division of the Tisch MS Research Center of New York proudly announces Food and Drug Administration (FDA) approval of autologous, mesenchymal stem cell-derived neural progenitor cells (MSC-NPs) as an Investigational New Drug (IND) for an open label, phase I clinical trial in...

August 14, 2013

More

Tisch MS Researchers Announce Breakthrough in Disease Monitoring

A Research team lead by Violaine Harris, Ph.D., at the Tisch MS Research Center of New York, has just published findings on a new method of measuring disease activity in patients with multiple sclerosis (MS) (Harris, et al, Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis,...

July 26, 2013

More

Stem Cell Trial Update: July 15th, 2013

Tisch MS Research Center of New York has formally submitted a response to the Food and Drug Administration’s (FDA) clinical hold on our proposed Phase I trial of Mesenchymal Stem Cell-Derived Neural Progenitors in the treatment of multiple sclerosis. Per agency rules, this submission necessitates a...

July 15, 2013

More

Journal Club: July 12, 2013

Violaine Harris (Tisch MSRCNY) presented the following article in Journal Club. Article Title: A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis Reference: S.D. Shields, PhD, X. Cheng, PhD, A. Gasser, PhD, C.Y. Saab, PhD, L. Tyrrell, MS, E.M. Eastman, BS, M...

July 12, 2013

More

Journal Club: June 21, 2013

Tamara Vyshkina (Tisch MSRCNY) presented the following article in Journal Club. Article Title: Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis Reference: M.A. Rocca, MD, P. Valsasina, MSc, V. Martinelli, MD, P. Misci, MSc, A. Falini, MD, G. Comi, MD, and M...

June 21, 2013

More

Tisch MS Research Center Requests Meeting with FDA

On Wednesday, June 12, 2013, Dr. Saud A. Sadiq and Dr. Violaine Harris met with a congressional supporter of our stem cell program. Following this discussion, The Tisch MS Research Center of New York submitted additional information to the FDA on June 18, 2013 and requested a formal meeting with...

June 20, 2013

More

Dr. Sadiq Interviewed in Science World Report

Check out an interview with Dr. Sadiq, titled "Stem Cells Hold Potential to Repair Immune Responses in MS Patients" featured on Science World Report.

June 18, 2013

More

New York Magazine Names Dr. Saud A. Sadiq a Best Doctor for 2013

Congratulations to Dr. Sadiq for his neurology listing in New York Magazine’s 2013 Best Doctor’s Issue ! This is a great achievement and acknowledgement of the hard work and dedication that happens on a daily basis at the IMSMP and Tisch MS Research Center of New York!

June 17, 2013

More

Grand Rounds: May 15, 2013

Dr. Stephen G. Waxman, MD, PhD, Bridget Marie Flaherty Professor of Neurology and Professor of Neurobiology and of Pharmacology and Director, Center for Neuroscience and Regeneration Research, Yale University School of Medicine, presented a Grand Rounds lecture at the Tisch MS Research Center of...

May 20, 2013

More

Journal Club: May 17, 2013

Forrest Anderson (Tisch MSRCNY) presented the following article in Journal Club. Article Title: Increased CD8+ T cell Response to Epstein-Barr Virus Lytic Antigens in the Active phase of Multiple Sclerosis Reference: D.F. Angelini, B. Serafini, E. Piras, M. Severa, E.M. Coccia, B. Rosicarelli, S...

May 20, 2013

More

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.